ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $6,000 | -33.3% | 1,500 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $9,000 | +50.0% | 1,500 | 0.0% | 0.01% | +40.0% |
Q1 2019 | $6,000 | +100.0% | 1,500 | 0.0% | 0.01% | +150.0% |
Q4 2018 | $3,000 | – | 1,500 | +1400.0% | 0.00% | – |
Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 100 | -50.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -75.0% | 200 | -72.4% | 0.00% | -100.0% |
Q4 2016 | $4,000 | +300.0% | 724 | +262.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -80.0% | 200 | -66.7% | 0.00% | -100.0% |
Q4 2015 | $5,000 | +150.0% | 600 | +177.8% | 0.00% | +200.0% |
Q3 2015 | $2,000 | – | 216 | +575.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 32 | -89.8% | 0.00% | -100.0% |
Q1 2015 | $3,000 | 0.0% | 315 | -37.0% | 0.00% | 0.0% |
Q4 2014 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |